These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38296734)

  • 1. Retraction notice to "LncRNA DICER1-AS1 promotes the proliferation, invasion and autophagy of osteosarcoma cells via miR-30b/ATG5" [Biomed. Pharmacother., 104 (2018) 110-118].
    Gu Z; Hou Z; Zheng L; Wang X; Wu L; Zhang C
    Biomed Pharmacother; 2024 Mar; 172():116198. PubMed ID: 38296734
    [No Abstract]   [Full Text] [Related]  

  • 2. LncRNA DICER1-AS1 promotes the proliferation, invasion and autophagy of osteosarcoma cells via miR-30b/ATG5.
    Gu Z; Hou Z; Zheng L; Wang X; Wu L; Zhang C
    Biomed Pharmacother; 2018 Aug; 104():110-118. PubMed ID: 29772430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Highly enriched exosomal lncRNA OIP5-AS1 regulates osteosarcoma tumor angiogenesis and autophagy through miR-153 and ATG5.
    Li Y; Lin S; Xie X; Zhu H; Fan T; Wang S
    Am J Transl Res; 2021; 13(5):4211-4223. PubMed ID: 34150009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retraction notice to: "LncRNA DANCR silence inhibits SOX5-medicated progression and autophagy in osteosarcoma via regulating miR-216a-5p" [Biomed. Pharmacother. 122 (2019) 109707].
    Pan Z; Wu C; Li Y; Li H; An Y; Wang G; Dai J; Wang Q
    Biomed Pharmacother; 2023 Oct; 166():114876. PubMed ID: 37353384
    [No Abstract]   [Full Text] [Related]  

  • 5. Retraction notice to "LNCRNA CDKN2B-AS1 regulates mesangial cell proliferation and extracellular matrix accumulation via miR-424-5p/HMGA2 axis" [Biomed. Pharmacother. 121 (2020) 109622].
    Li Y; Zheng LL; Huang DG; Cao H; Gao YH; Fan ZC
    Biomed Pharmacother; 2023 Aug; 164():114728. PubMed ID: 37087341
    [No Abstract]   [Full Text] [Related]  

  • 6. Retraction notice to "miR-367 regulation of DOC-2/DAB2 interactive protein promotes proliferation, migration and invasion of osteosarcoma cells" [Biomed. Pharmacother. 95 (2017) 120-128].
    Cai W; Jiang H; Yu Y; Xu Y; Zuo W; Wang S; Su Z
    Biomed Pharmacother; 2023 Apr; 160():114282. PubMed ID: 36725469
    [No Abstract]   [Full Text] [Related]  

  • 7. Retraction notice to "MicroRNA-30b promotes lipopolysaccharide-induced inflammatory injury and alleviates autophagy through JNK and NF-κB pathways in HK-2 cells" [Biomed. Pharmacother. 101 (2018) 842-851].
    Zhang L; Li J; Cui L; Shang J; Tian F; Wang R; Xing G
    Biomed Pharmacother; 2020 Aug; 128():110279. PubMed ID: 32487440
    [No Abstract]   [Full Text] [Related]  

  • 8. Retraction notice to "Long noncoding RNA HOXD-AS1 promotes non-small cell lung cancer migration and invasion through regulating miR-133b/MMP9 axis" [Biomed. Pharmacother. 106 (2018) 156-162].
    Xia H; Jing H; Li Y; Lv X
    Biomed Pharmacother; 2023 Dec; 169():115376. PubMed ID: 38016887
    [No Abstract]   [Full Text] [Related]  

  • 9. Retraction notice to "lncRNA PEG10 promotes cell survival, invasion and migration by sponging miR-134 in human bladder cancer" [Biomed. Pharmacother. 114 (2019) 108814].
    Jiang F; Qi W; Wang Y; Wang W; Fan L
    Biomed Pharmacother; 2022 Jan; 145():112511. PubMed ID: 34895810
    [No Abstract]   [Full Text] [Related]  

  • 10. Knockdown of lncRNA LINC00662 suppresses malignant behaviour of osteosarcoma cells via competition with miR-30b-3p to regulate ELK1 expression.
    Wang B; Xu Z; Wang X; Xia S; Cai P; Wang M; Gao Z
    J Orthop Surg Res; 2022 Feb; 17(1):74. PubMed ID: 35123530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retraction notice to "Long non-coding RNA TTN-AS1 promotes tumorigenesis of ovarian cancer through modulating the miR-139-5p/ROCK2 axis" [Biomed. Pharmacother. 125 (2020) 109882].
    Liu X; Li Y; Wen J; Qi T; Wang Y
    Biomed Pharmacother; 2022 Sep; 153():113356. PubMed ID: 35835667
    [No Abstract]   [Full Text] [Related]  

  • 12. Long non-coding RNA (LncRNA) MRPL23-AS1 promotes tumor progression and carcinogenesis in osteosarcoma by activating Wnt/β-catenin signaling via inhibiting microRNA miR-30b and upregulating myosin heavy chain 9 (MYH9).
    Zhang H; Liu S; Tang L; Ge J; Lu X
    Bioengineered; 2021 Dec; 12(1):162-171. PubMed ID: 33356805
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA HNF1A-AS1 functioned as an oncogene and autophagy promoter in hepatocellular carcinoma through sponging hsa-miR-30b-5p.
    Liu Z; Wei X; Zhang A; Li C; Bai J; Dong J
    Biochem Biophys Res Commun; 2016 May; 473(4):1268-1275. PubMed ID: 27084450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retraction notice to "Long noncoding RNA TP73-AS1 promotes non-small cell lung cancer progression by competitively sponging miR-449a/EZH2" [Biomed. Pharmacother. 104 (2018) 705-711].
    Zhang L; Fang F; He X
    Biomed Pharmacother; 2023 Dec; 168():115377. PubMed ID: 37802724
    [No Abstract]   [Full Text] [Related]  

  • 15. DICER1-AS1 Promotes the Malignant Behaviors of Colorectal Cancer Cells by Regulating miR-296-5p/STAT3 Axis.
    Ma C; Ma N; Qin L; Miao C; Luo M; Liu S
    Cancer Manag Res; 2020; 12():10035-10046. PubMed ID: 33116860
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retraction notice to "Knockdown of long non-coding RNA HOXD-AS1 inhibits the progression of osteosarcoma" [Biomed. Pharmacother., 98 (2018) 899 - 906].
    Qu Y; Zheng S; Kang M; Dong R; Zhou H; Zhao D; Zhao J
    Biomed Pharmacother; 2024 Feb; 171():116197. PubMed ID: 38296733
    [No Abstract]   [Full Text] [Related]  

  • 17. Retraction notice to "Sinomenine inhibits proliferation, migration, invasion and promotes apoptosis of prostate cancer cells by regulation of miR-23a" [Biomed. Pharmacother. 112 (2019) 108592].
    Xu F; Li Q; Wang Z; Cao X
    Biomed Pharmacother; 2022 Apr; 148():112781. PubMed ID: 35272893
    [No Abstract]   [Full Text] [Related]  

  • 18. Retraction notice to "LncRNA SNHG16 promotes tumor growth of pancreatic cancer by targeting miR-218-5p" [Biomed. Pharmacother. 114 (2019) 108862].
    Liu S; Zhang W; Liu K; Liu Y
    Biomed Pharmacother; 2024 Feb; 171():116188. PubMed ID: 38296726
    [No Abstract]   [Full Text] [Related]  

  • 19. Retraction notice to "Knockdown of lncRNA-H19 inhibits cell viability, migration and invasion while promotes apoptosis via microRNA-143/RUNX2 axis in retinoblastoma" [Biomed. Pharmacother. 109 (2019) 798-805].
    Qi D; Wang M; Yu F
    Biomed Pharmacother; 2022 Jun; 150():112855. PubMed ID: 35341635
    [No Abstract]   [Full Text] [Related]  

  • 20. Retraction notice to: "LncRNA SNHG3 promotes the growth and metastasis of colorectal cancer by regulating miR-539/RUNX2 axis" Biomed. Pharmacother. 125 (2020) 110039.
    Wen D; Li S; Jiang W; Zhao S; Liu J; Zhu J
    Biomed Pharmacother; 2023 Oct; 166():114877. PubMed ID: 37353385
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.